Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rTMS and Biomarkers in Treatment-Resistant Depression
NCT06163625Recruiting
- Sponsor
- Unity Health Toronto
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Unity Health Toronto. Primary endpoint: Hamilton Rating Scale for Depression at 8 weeks. Started Jan 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06163625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06163625.